|
|
|
| Investigation and analysis of the incidence of metabolic syndrome and its related risk factors in outpatients with schizophrenia |
| Xie Ji-qun1 YU Wei-lu2 OUYANG Shao-wei1 ZHONG Yuan-hui1▲ ZHANG Zhi-bin1 |
1.Compulsory Medical Institute,Mental Hospital of Guangzhou Municipal Civil Affairs Bureau,Guangdong Province,Guangzhou 510430,China;
2.First Department of General Psychiatry,the Third People′s Hospital of Meizhou City,Guangdong Province,Meizhou 514089,China |
|
|
|
|
Abstract Objective Toexplore the incidence and risk factorsof metabolic syndrome(MS)in outpatients with schizophrenia.MethodsThere were212 casesof schizophrenia diagnosed in the Third People′s Hospital of Meizhou City from March to October 2017 were selected,and 212 patients with schizophrenia were diagnosed according to ICD-10.Results There were 197 patients were collected,the response rate was 92.3%,and 25.4%(50/197)patients had MS.Under the condition of entering levelα=0.05 and excluding levelβ=0.10,two classification Logistic regression analysis was carried out.MS was set as dependent variable,demographic basic data and clinical data were set as independent variables.The results of Logistic regression showed that the higher level the FBG and SBP get,the higher prevalence MS had,while the higher the education level and HDL-C,the lower the prevalence of MS.Conclusion About 1/4 of outpa tients with schizophrenia have MS.In addition,high FBG,high SBP,low educational background and low(HDL-C)may be the causes of MSin outpatients with schizophrenia.Furthermore,MSis the risk fator for,cardiovascular disease.
|
|
|
|
|
|
| [1] |
陈蕊，郑伟，冷传芳，等.精神分裂症患者精神残疾的影响因素研究进展[J].神经疾病与精神卫生，2017，17（1）：63-66.
|
| [3] |
刘峥荣，郑伟，陈蕊，等.治疗抗精神病药物所致高催乳素血症的研究进展[J].神经疾病与精神卫生，2017，17（4）：296-298.
|
| [2] |
Leucht S，Cipriani A，Spineli L，et al.Comparative efficacy and tolerability of 15 antipsychotic drugs in schizophrenia：a multiple-treatments meta-analysis[J].Lancet，2013，382（9896）：951-962.
|
| [4] |
Laursen TM，Nordentoft M，Mortensen PB.Excess early mortalityin schizophrenia[J].Ann Rev Clin Psychol，2014，10（10）：425-448.
|
| [5] |
赵帅，周晓琴，夏海龙，等.住院精神分裂症患者心血管疾病发生风险研究[J].中国神经精神疾病杂志，2017，43（9）：539-543.
|
| [6] |
李春燕，黄淑田，殷耀武.精神分裂症患者合并代谢综合征的研究进展[J].中西医结合心脑血管病杂志，2009，7（6）：728-729.
|
| [7] |
程灶火，凌卫明，周晓琴，等.精神分裂症患者代谢综合征的患病率及影响因素研究[J].中华行为医学与脑科学杂志，2011，20（11）：1012-1015.
|
| [8] |
Hagg S，Lindblom Y，Mjorndal T，et al.High prevalence of the metabolic syn drome among a Swedish cohort of patients with schizophrenia[J].Int Clin Psychopharmacol，2006，21（2）：93-98.
|
| [9] |
De Hert MA，Van WR，Van ED，et al.Prevalence of the metabolic syndrome in patients with schizophrenia treated with antipsychotic medication[J].Schizophr Res，2006，83（1）：87-93.
|
| [10] |
Cohn T，Prud'Homme D，Streiner D，et al.Characterizing coronary heart disease risk in chronic schizophrenia：high prevalence of the metabolic syndrome[J].Can J Psychiatry，2004，49（11）：753-760.
|
| [11] |
朱卫明，易正辉，丁宇杰，等.慢性精神分裂症患者伴发代谢综合症临床研究[J].临床心身疾病杂志，2008，14（6）：484-486.
|
| [12] |
Guerrero-Romero F，Rodríguez-Morán M.Concordance between the 2005 international diabetes federation definition for diagnosingmetabolic syndromewith the National Cholesterol Education Program adult treatment panelⅢand the World Health Organization definitions[J].Diabetes Care，2005，28（10）：2588-2589.
|
| [13] |
Zhang XY，Chen DC，Xiu MH，et al.Cigarette smoking and cognitive function in Chinese male schizophrenia：a casecontrol study[J].PLoSOne，2012，7（5）：e36563.
|
| [14] |
Wang J，Li MD.Common and unique biological pathways associated with smoking initiation/progression，nicotine dependence，and smoking cessation[J].Neuropsychopharmacology，2010，35（3）：702-719.
|
| [15] |
Sarafidis PA，Nilsson PM.The metabolic syndrome：a glance at its history[J].JHypertension，2006，24（4）：621-624.
|
| [16] |
钟桂锦.慢性精神分裂症患者代谢综合征的相关影响因素分析及预防干预[J].现代诊断与治疗，2017，28（9）：1725-1726.
|
| [17] |
朱玉妹，朱明环，杨嘉宇，等.长期住院精神分裂症患者骨质疏松状况及其危险因素调查[J].临床精神医学杂志，2017，27（4）：257-259.
|
| [18] |
尹晓丹.精神分裂症伴发代谢综合征护理干预的研究进展[J].继续医学教育，2017，31（3）：120-122.
|
|
|
|
